Printer Friendly

GEORGE J. STASEN JOINS TOPOX AS EXECUTIVE VICE PRESIDENT AND CHIEF OPERATING OFFICER

 GEORGE J. STASEN JOINS TOPOX AS
 EXECUTIVE VICE PRESIDENT AND CHIEF OPERATING OFFICER
 CHADDS FORD, Pa., July 15 /PRNewswire/ -- Topox, Inc. (AMEX: TPO.EC) said today it is pleased to announce that George J. Stasen of Newtown Square, Pa., joined the company as executive vice president and chief operating officer.
 Stasen is a senior investment professional whose experience spans 45 years. He chaired the Trust Investment Policy Committees (domestic and international) of Philadelphia's Girard Bank; created the first medical sector, equity mutual fund -- Medical Technology Fund -- and its companion -- Emerging Medical Technology Fund; established the life science investment research activity of Bradley & Co.; pioneered in the application of computer technology to many phases of investment work, including a national investment newspaper, The Financial Weekly, and served as a senior investment counsellor at Scudder, Stevens and Clark. A noted and prolific writer, he will shortly have published a "how to" book for the inexperienced stock market investor.
 /delval/
 -0- 7/15/92
 /CONTACT: Jack Cantwell, chairman and chief executive officer of Topox, 800-38-TOPOX, or 215-459-4655/
 (TPO) CO: Topox, Inc. ST: Pennsylvania IN: SU: PER


JS-MK -- PH028 -- 9653 07/15/92 15:04 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 15, 1992
Words:192
Previous Article:INPUT/OUTPUT FILES SECONDARY REGISTRATION
Next Article:AMERICA ONLINE, VENTANA PRESS RELEASE COMPANION SOFTWARE LIBRARY AND BOOK; COMPUTER USERS HAVE NEW INCENTIVE TO TRY DOWNLOADING


Related Articles
TOPOX REPORTS RESULTS FOR FISCAL YEAR ENDED MARCH 31, 1992
TOPOX ANNOUNCES RESULTS FOR THE FIRST QUARTER ENDED JUNE 30, 1992
TOPOX ANNOUNCES THE FDA HAS RULED FAVORABLY ON ITS 510K APPLICATION
TOPOX AND APPLIED BIOSENSORS TO DEVELOP SKIN TISSUE MONITORING SYSTEM
TOPOX: AGREEMENT SIGNED TO MANUFACTURE INNOVATIVE MEDICAL DEVICES
TOPOX TO CHANGE NAME
TOPOX TO CHANGE NAME
SUPRA MEDICAL CORP. RELEASES SECOND QUARTER RESULTS
TRANS-ATLANTIC ALLIANCE TO ADVANCE SKIN DISORDER RESEARCH AND TREATMENT
SUPRA MEDICAL REALIGNS MANAGEMENT

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters